Anavex Life Sciences Corp. Shares Close the Week 26.3% Higher - Weekly Wrap

The company saw its shares close the week 26.3% higher than last week, with trading volume lower than its 30 day average.

Mar 12, 2021 by Kwhen Finance Editors

Anavex Life Sciences Corp. Shares Close the Week 26.3% Higher - Weekly Wrap
Anavex Life Sciences Corp. shares closed this week 26.3% higher than it did at the end of last week. The stock is currently up 174.4% year-to-date, up 459.2% over the past 12 months, and up 227.9% over the past five years. This week, the Dow Jones Industrial Average rose 3.7%, and the S&P 500 rose 3.8%.

Trading Activity

  • Shares traded as high as $15.17 and as low as $11.92 this week.
  • Trading volume this week was 22.7% higher than the 10-day average and 9.9% lower than the 30-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 1.0.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
  • MACD, a trend-following momentum indicator, indicates a downward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.

Market Comparative Performance

  • The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis
  • The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis
  • The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
Anavex Life Sciences Corp.4.1174.4459.2
Dow Jones Industrial Average0.58.245.2-0.384.0
S&P 500 Index0.66.049.9-0.683.0
Health Care0.72.032.3-3.362.2

Peer Group Comparative Performance

  • The company's stock price performance year-to-date beats the peer average by 452.9%
  • The company's stock price performance over the past 12 months beats the peer average by 172.1%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
Anavex Life Sciences Corp.AVXL0174.4459.2
Peer AvgN/A-174.031.5168.8-9.1168.7
Corcept Therapeutics Incorporated.CORT28.5-1.4138.8
Ligand Pharmaceuticals IncorporatedLGND-879.464.1100.5
BioCryst Pharmaceuticals Inc.BCRX-12.369.7471.9-7.2717.7
Palatin Technologies Inc.PTN-6.917.973.2-38.4125.5
ARCA biopharma Inc.ABIO07.559.6

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: